Gapping up
In reaction to strong earnings/guidance: TLYS +18%, PSUN +16.5%, RYAAY +7.4%, (Guidance) AVGO +7.2%, ENB +6.5%, LB +5.4%, (SSS) SHLD +2.2%, COST +0.6%, (SSS).
M&A news: HE +17% (agreed to combine in transaction valued at ~$4.3 billion), ARIA +1.7% (speculation that Asterzenca (AZN) and Shire (SHPG) are interested), KOG +1.1% (Whiting Petroleum Stockholders Approve Acquisition of Kodiak Oil & Gas), BBY +1% (to sell its Five Star Business in China)
Select China related names showing strength after Shanghai gained 4% last night: PTR +5.5%, LFC +2.7%, JRJC +2.6%, CEO +2.6%
Other news: CACH +64.5% (announces review of strategic alternatives), ARRY +23.8% (to regain worldwide rights to Binimetinib), APDN +19.5% (signs with fourth federal agency), OXF +18.8% (disclosed that on December 2, 2014, it was notified the NYSE that it regained compliance with the share price continued listing standard of the NYSE), SCOK +18.2% (begins construction of second aboveground syngas facility; plans to double output capacity), PLUG +15.1% (signs multi-year ReliOn fuel cell contract with communications company valued at $20 mln), CDXS +12.6% (announced it has developed a novel enzyme therapeutic product candidate for the potential treatment of phenylketonuria), APPY +5.3% (will provide business update on Monday, Dec 8 at 4:30 following FDA request for additional info on APPY1 direct de novo submission), CTIC +4.1% (receives $15 mln milestone payment for TRISENOX), AMBA +3% (ahead of earnings after the close), JBLU +2.8% (peer Ryanair (RYAAY) reported Nov traffic, raised profit outlook), MTOR +2.3% (still checking), DAL +2.1% (peer Ryanair (RYAAY) reported Nov traffic, raised profit outlook), UL +2% (to create stand alone business unit within Spreads division), PRA +1.8% (has authorized a special dividend of $2.65 per common share, increased its regular dividend by 3.3% to $0.31/share and adds to share repurchase authorization ), ALV +1.8% (cont strength after confirming will supply replacement airbag inflators to be used by Honda (HMC)), ISIS +1.7% (ISIS-APOCIII Rx Phase 2 study in patients with familial chylomicronemia published ), UN +1.7%, RFMD +1.6% (may be in symp with AVGO earnings), FEYE +1.3% (on going volatility surrounding Sony sec breach), EJ +1.3% (announced the details of the partial spin off of Leju Holdings (LEJU)), HDNG +1.1% (light volume; Privet Fund disclosed 7% stake; has engaged in discussions with management regarding the operations and strategic direction), VA +0.8% (peer Ryanair (RYAAY) reported Nov traffic, raised profit outlook)
Analyst comments: MBLY +4.3% (upgraded to Buy from Hold at Deutsche Bank), INFI +2.7% (upgraded to Outperform from Neutral at Credit Suisse), ORAN +2.3% (upgraded to Neutral from Underperform at Credit Suisse), CSX +1.2% (upgraded to Buy from Neutral at Citigroup), PG +1% (upgraded to Outperform from Neutral at Credit Suisse), AA +0.5% (initiated with a Outperform at Wells Fargo)
In reaction to strong earnings/guidance: TLYS +18%, PSUN +16.5%, RYAAY +7.4%, (Guidance) AVGO +7.2%, ENB +6.5%, LB +5.4%, (SSS) SHLD +2.2%, COST +0.6%, (SSS).
M&A news: HE +17% (agreed to combine in transaction valued at ~$4.3 billion), ARIA +1.7% (speculation that Asterzenca (AZN) and Shire (SHPG) are interested), KOG +1.1% (Whiting Petroleum Stockholders Approve Acquisition of Kodiak Oil & Gas), BBY +1% (to sell its Five Star Business in China)
Select China related names showing strength after Shanghai gained 4% last night: PTR +5.5%, LFC +2.7%, JRJC +2.6%, CEO +2.6%
Other news: CACH +64.5% (announces review of strategic alternatives), ARRY +23.8% (to regain worldwide rights to Binimetinib), APDN +19.5% (signs with fourth federal agency), OXF +18.8% (disclosed that on December 2, 2014, it was notified the NYSE that it regained compliance with the share price continued listing standard of the NYSE), SCOK +18.2% (begins construction of second aboveground syngas facility; plans to double output capacity), PLUG +15.1% (signs multi-year ReliOn fuel cell contract with communications company valued at $20 mln), CDXS +12.6% (announced it has developed a novel enzyme therapeutic product candidate for the potential treatment of phenylketonuria), APPY +5.3% (will provide business update on Monday, Dec 8 at 4:30 following FDA request for additional info on APPY1 direct de novo submission), CTIC +4.1% (receives $15 mln milestone payment for TRISENOX), AMBA +3% (ahead of earnings after the close), JBLU +2.8% (peer Ryanair (RYAAY) reported Nov traffic, raised profit outlook), MTOR +2.3% (still checking), DAL +2.1% (peer Ryanair (RYAAY) reported Nov traffic, raised profit outlook), UL +2% (to create stand alone business unit within Spreads division), PRA +1.8% (has authorized a special dividend of $2.65 per common share, increased its regular dividend by 3.3% to $0.31/share and adds to share repurchase authorization ), ALV +1.8% (cont strength after confirming will supply replacement airbag inflators to be used by Honda (HMC)), ISIS +1.7% (ISIS-APOCIII Rx Phase 2 study in patients with familial chylomicronemia published ), UN +1.7%, RFMD +1.6% (may be in symp with AVGO earnings), FEYE +1.3% (on going volatility surrounding Sony sec breach), EJ +1.3% (announced the details of the partial spin off of Leju Holdings (LEJU)), HDNG +1.1% (light volume; Privet Fund disclosed 7% stake; has engaged in discussions with management regarding the operations and strategic direction), VA +0.8% (peer Ryanair (RYAAY) reported Nov traffic, raised profit outlook)
Analyst comments: MBLY +4.3% (upgraded to Buy from Hold at Deutsche Bank), INFI +2.7% (upgraded to Outperform from Neutral at Credit Suisse), ORAN +2.3% (upgraded to Neutral from Underperform at Credit Suisse), CSX +1.2% (upgraded to Buy from Neutral at Citigroup), PG +1% (upgraded to Outperform from Neutral at Credit Suisse), AA +0.5% (initiated with a Outperform at Wells Fargo)